SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Nov-15 5:15 PM View: | Emergent BioSolutions, Inc. (EBS) | 13-Nov-15 | Market Sale | 3,376 | $36.50 | $123,224.00 | (12%) 28.56K to 25.18K | (147%) |
13-Nov-15 4:49 PM View: | Emergent BioSolutions, Inc. (EBS) | 12-Nov-15 | Option Exercise | 10,094 | $20.94 | $211,368.00 | 33% 30.23K to 40.32K | |
13-Nov-15 4:49 PM View: | Emergent BioSolutions, Inc. (EBS) | 12-Nov-15 | Market Option Sale | 3,530 | $36.00 | $127,080.00 | (9%) 40.32K to 36.79K | (150%) |
13-Nov-15 4:49 PM View: | Emergent BioSolutions, Inc. (EBS) | 12-Nov-15 | Market Sale | 6,564 | $36.00 | $236,304.00 | (18%) 36.79K to 30.23K | (150%) |
13-Nov-15 4:49 PM View: | Emergent BioSolutions, Inc. (EBS) | 11-Nov-15 | Payment of Exercise | 1,671 | $35.88 | $59,955.50 | (3%) 56.26K to 54.59K | (151%) |
13-Nov-15 4:49 PM View: | Emergent BioSolutions, Inc. (EBS) | 11-Nov-15 | Option Exercise | 19,468 | $24.38 | $474,677.00 | 53% 36.79K to 56.26K | |
13-Nov-15 4:49 PM View: | Emergent BioSolutions, Inc. (EBS) | 11-Nov-15 | Market Option Sale | 26,032 | $35.50 | $924,202.00 | (48%) 54.59K to 28.56K | (154%) |
12-Mar-15 5:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 10-Mar-15 | Grant | 10,762 | -- | -- | 39% 27.63K to 38.39K | |
12-Mar-15 5:01 PM View: | Emergent BioSolutions, Inc. (EBS) | 10-Mar-15 | Payment of Exercise | 1,594 | $29.00 | $46,226.00 | (4%) 38.39K to 36.79K | (211%) |
29-Dec-14 3:15 PM View: | Emergent BioSolutions, Inc. (EBS) | 12-Nov-14 | Payment of Exercise | 1,577 | $24.41 | $38,494.60 | (5%) 29.2K to 27.63K | (269%) |
12-Mar-14 3:12 PM View: | Emergent BioSolutions, Inc. (EBS) | 11-Mar-14 | Grant | 14,060 | $28.09 | $394,945.00 | 93% 15.14K to 29.2K | 221% |
03-Feb-14 2:57 PM View: | Emergent BioSolutions, Inc. (EBS) | 12-Nov-13 | Grant | 15,142 | -- | -- | 5608% 0.27K to 15.41K | |
01-Aug-12 11:53 AM View: | Human Genome Sciences Inc. (HGSI) | 30-Jul-12 | Disposition (change in control) | 49,842 | $14.25 | $710,248.00 | (100%) 49.84K to 0 | < 1% |
26-Jul-12 11:09 AM View: | Human Genome Sciences Inc. (HGSI) | 25-Jul-12 | Option Exercise | 31,480 | $1.86 | $58,609.60 | 171% 18.36K to 49.84K | |
27-Jul-11 12:55 PM View: | Human Genome Sciences Inc. (HGSI) | 26-Jul-11 | Option Exercise | 18,362 | $9.47 | $173,859.00 | 100% 0 to 18.36K | |
04-May-11 2:57 PM View: | Human Genome Sciences Inc. (HGSI) | 02-May-11 | Option Exercise | 7,347 | $4.92 | $36,147.20 | 100% 0 to 7.35K | |
04-May-11 2:57 PM View: | Human Genome Sciences Inc. (HGSI) | 02-May-11 | Market Option Sale (Planned) | 7,347 | $30.00 | $220,410.00 | (100%) 7.35K to 0 | 5% |
29-Apr-11 3:37 PM View: | Human Genome Sciences Inc. (HGSI) | 28-Apr-11 | Option Exercise | 39,966 | $1.82 | $72,935.50 | 100% 0 to 39.97K | |
29-Apr-11 3:37 PM View: | Human Genome Sciences Inc. (HGSI) | 28-Apr-11 | Market Option Sale (Planned) | 39,966 | $30.00 | $1,198,980.00 | (100%) 39.97K to 0 | 1% |
02-Sep-10 2:38 PM View: | Human Genome Sciences Inc. (HGSI) | 01-Sep-10 | Option Exercise | 50,000 | $4.92 | $246,000.00 | 100% 0 to 50.0K | |
02-Sep-10 2:38 PM View: | Human Genome Sciences Inc. (HGSI) | 01-Sep-10 | Market Option Sale | 50,000 | $30.02 | $1,500,780.00 | (100%) 50.0K to 0 | 19% |
30-Aug-10 4:31 PM View: | Human Genome Sciences Inc. (HGSI) | 27-Aug-10 | Option Exercise | 16,079 | $4.92 | $79,108.70 | 100% 0 to 16.08K | |
30-Aug-10 4:31 PM View: | Human Genome Sciences Inc. (HGSI) | 27-Aug-10 | Market Option Sale (Planned) | 16,079 | $28.50 | $458,287.00 | (100%) 16.08K to 0 | 15% |
30-Aug-10 4:31 PM View: | Human Genome Sciences Inc. (HGSI) | 26-Aug-10 | Option Exercise | 13,050 | $4.92 | $64,206.00 | 100% 0 to 13.05K | |
30-Aug-10 4:31 PM View: | Human Genome Sciences Inc. (HGSI) | 26-Aug-10 | Market Option Sale (Planned) | 13,050 | $28.53 | $372,361.00 | (100%) 13.05K to 0 | 15% |
27-Jul-10 3:06 PM View: | Human Genome Sciences Inc. (HGSI) | 26-Jul-10 | Option Exercise | 21,871 | $0.52 | $11,372.90 | 100% 0 to 21.87K | |
27-Jul-10 3:06 PM View: | Human Genome Sciences Inc. (HGSI) | 26-Jul-10 | Market Option Sale (Planned) | 21,871 | $27.05 | $591,525.00 | (100%) 21.87K to 0 | 11% |
01-Dec-09 12:10 PM View: | Human Genome Sciences Inc. (HGSI) | 30-Nov-09 | Option Exercise | 24,996 | $0.52 | $12,997.90 | 56% 44.7K to 69.7K | |
01-Dec-09 12:10 PM View: | Human Genome Sciences Inc. (HGSI) | 30-Nov-09 | Market Option Sale (Planned) | 24,996 | $27.37 | $684,141.00 | (36%) 69.7K to 44.7K | 12% |
01-Dec-09 12:10 PM View: | Human Genome Sciences Inc. (HGSI) | 30-Nov-09 | Market Sale (Planned) | 44,700 | $27.37 | $1,223,440.00 | (100%) 44.7K to 0 | 12% |
18-Aug-06 2:35 PM View: | Human Genome Sciences Inc. (HGSI) | 16-Aug-06 | Market Sale | 5,300 | $9.79 | $51,887.00 | (11%) 50.0K to 44.7K | (148%) |
16-Aug-05 1:46 PM View: | Human Genome Sciences Inc. (HGSI) | 15-Aug-05 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K |